FDA Inspection 1272748 — 3D Imaging Drug Design And Development LLC
The FDA completed an inspection of 3D Imaging Drug Design And Development LLC on Jun 13, 2025 in Little Rock, AR. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Jun 13, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Little Rock, AR (United States)